Home › Ear Infections › NCT06944795
SWIR Otoscopy Study
A Short Wave Infrared Otoscope for Objective Middle Ear Effusion Diagnosis
Who can join
Ages 1 to 17 · All sexes
Full eligibility criteria
Inclusion Criteria: * Ages 1-17 * Being seen in the Ear, Nose, and Throat Clinic at Lucile Packard Childrens Hospital * Undergoing tympanostomy tube placement as part of standard of care * Parents and/or patient has the ability to understand and the willingness to sign a written informed consent form or assent form. Exclusion Criteria: * Patients under 1 year of age or 18 and older * Participants not meeting the inclusion criteria
About the study
The aim of this study is to provide preliminary data to support future studies to demonstrate that the short wave infrared (SWIR) otoscope is a better diagnostic tool than a white light otoscope for diagnosing middle ear infections (otitis media). Patients who are having a tympanostomy tube placement procedure will be participating in this study. Imaging will be performed with the white light otoscope and the SWIR otoscope to determine presence of absence of fluid. The SWIR otoscope will gather SWIR data and white light data simultaneously. As part of standard of care, patients who come in for this procedure have removal of middle ear fluid as part of their procedure, which will confirm presence or absence of fluid.
What is being tested
- SWIR device (device)
Sponsor: Stanford University · Participants: 100 · Started: Apr 30, 2026
Contact the study team
Official record on ClinicalTrials.gov — NCT06944795
Locations in the U.S.
| California | Stanford University, Palo Alto |
Conditions
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.